News within Clinical Medicine
Dr Sara Naimimohasses receives Dean's Research Initiatives Fund 2016
Dr Naimimohasses received the funding for a pilot study to develop a non-invasive bioclinical tool for the identification of obesity related fatty liver disease.
Non-Alcoholic Fatty Liver Disease is defined as an excess of fat on the liver in the absence of increased alcohol intake. There are several factors that increase the risk of developing Fatty Liver and these include Diabetes (type 2), high blood pressure, high cholesterol and being over-weight or obese.
As the name suggests, non-alcoholic fatty liver disease (NAFLD), is different to liver disease caused by excessive alcohol intake. NAFLD is common in people with type 2 diabetes, high BMIs and/or having a high intake of fat and sugar, commonly referred to as the 'Western diet'.
It has become the most common liver disease in western countries and is the number one cause of cirrhosis and hepatocellular carcinoma in the Western world.
Photograph : Left Dr Sara Naimimohasses with Professor Mary McCarron (Dean)